B

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

Director – Publication Strategy and Execution

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNorth Carolina, USANo salary listed

About the Job

Requirements

  • An advanced scientific degree (PharmD, PhD, or MD/DO) is required.
  • At least 10 years of Medical Affairs experience in the pharmaceutical industry and/or relevant clinical or scientific experience, including leading scientific publications.
  • Experience developing and executing integrated publication strategies across pre-launch, launch, and post-launch phases, aligned with medical strategy, evidence-generation priorities, scientific platforms, congress milestones, and lifecycle management objectives.
  • Pipeline portfolio and rare disease experience, with the ability to adapt publication strategies across early- and late-stage assets, evolving evidence plans, and changing program priorities.
  • Expert knowledge of good publication practices and guidance, including GPP and ICMJE, and other standards related to scientific data communication.
  • Understanding of clinical trial design and execution, statistical methods, and clinical trial data reporting requirements.
  • Ability to define and track publication performance metrics, assess scientific communication impact, and use insights to optimize publication planning and execution.
  • Ability to collaborate, influence, and execute within large matrixed, cross-functional teams.
  • Experience managing and developing high-performing teams, including setting priorities, providing coaching and feedback, supporting professional growth, and fostering accountability in a matrixed environment.
  • Project management skills to manage multiple priorities and deliver outcomes, including publication planning, medical and technical writing, editing, and review.
  • Ability to think strategically, critically analyze complex data, and synthesize scientific information into clear communication strategies.
  • Written and verbal communication skills, with a track record of developing and delivering high-quality scientific content.
  • Proficiency with Microsoft Office applications and document management systems such as PubStrat, SharePoint, Veeva Vault, and Smartsheet.
  • Ability to travel domestically and internationally approximately 25% of the time.

Responsibilities

  • Serve as the subject matter expert on publication-related matters, working with internal and external disease area experts on relevant data, analysis, interpretation, communication, and publication planning.
  • Adhere to good publication practices and ensure compliance with company policies.
  • Develop and revise internal guidance and policies to support publication activities.
  • Deliver training to internal cross-functional teams and external partners as appropriate.
  • Lead development of medical and scientific publications and remain accountable for deliverables across hereditary angioedema and the pipeline portfolio.
  • Coordinate, allocate resources for, and in some cases execute development of abstracts, posters, oral presentations, manuscripts, and presentations for scientific and medical meetings to support publication plans for all compounds.
  • Coordinate resources for writing, editing, formatting, and submitting articles to peer-reviewed scientific journals and scientific and medical conferences.
  • Build and maintain relationships with clinical experts, journal editors, and congress personnel.
  • Manage the annual budget, work, and resource allocation, including ensuring contracts, statements of work, and invoices are submitted accurately and on time.
  • Manage vendors day to day to execute publications efficiently according to the Publications Policy and good publication practices.
  • Oversee maintenance of documents in the publication planning platform to ensure completeness, accuracy, and integrity, while staying current with good publication practices and ISMPP standards.

Desired Qualifications

  • Certification as a Medical Publication Professional (CMPP).
  • Hereditary angioedema, immunology, or rare disease experience.
  • Experience with digital and innovative publication approaches, including enhanced publications, plain language summaries, digital congress assets, and technology-enabled publication workflow tools.

About the Company

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

BioCryst Pharmaceuticals develops oral small-molecule drugs aimed at treating rare diseases, with a focus on hereditary angioedema (HAE). The company uses traditional cell biology and medicinal chemistry to design synthetic compounds that target specific protein pathways involved in disease. Its products work as oral therapies that modulate disease-related proteins to reduce symptoms and improve daily functioning, progressing from discovery through clinical trials toward commercialization. BioCryst differentiates itself by concentrating on rare diseases and pursuing oral, non-biologic treatments, leveraging a combined science approach and a patient-focused strategy to bring therapies to market. Its goal is to deliver meaningful, clinically validated treatments that enable patients to engage more fully in everyday activities and improve their quality of life, supported by its drug pipeline and potential licensing opportunities.

Company size
501-1,000
Company stage
IPO
Headquarters
Durham, NC
Founded
1986

Recently Posted Jobs

Explore more opportunities at BioCryst Pharmaceuticals

See more jobs